These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 445441)

  • 21. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer.
    Tong AW; Papayoti MH; Netto G; Armstrong DT; Ordonez G; Lawson JM; Stone MJ
    Clin Cancer Res; 2001 Mar; 7(3):691-703. PubMed ID: 11297266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progestin regulation of epidermal growth factor receptor in human mammary carcinoma cells.
    Murphy LJ; Sutherland RL; Stead B; Murphy LC; Lazarus L
    Cancer Res; 1986 Feb; 46(2):728-34. PubMed ID: 3000583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Examination of the direct effects of metabolic factors on somatotrope function in a non-human primate model, Papio anubis.
    Luque RM; Gahete MD; Valentine RJ; Kineman RD
    J Mol Endocrinol; 2006 Aug; 37(1):25-38. PubMed ID: 16901921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EGF receptors in R3230AC rat mammary carcinomas: characteristics and regulation in vitro and in vivo.
    Ryan PD; Hilf R
    Oncol Res; 1992; 4(4-5):181-92. PubMed ID: 1504378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucocorticoids inhibit cytokine-mediated eosinophil survival.
    Wallen N; Kita H; Weiler D; Gleich GJ
    J Immunol; 1991 Nov; 147(10):3490-5. PubMed ID: 1940348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells.
    Gucev ZS; Oh Y; Kelley KM; Rosenfeld RG
    Cancer Res; 1996 Apr; 56(7):1545-50. PubMed ID: 8603400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of estrogen action on the proliferation of MCF-7 human breast cancer cells in an improved culture medium.
    Furuya Y; Kohno N; Fujiwara Y; Saitoh Y
    Cancer Res; 1989 Dec; 49(23):6670-4. PubMed ID: 2819716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro growth inhibition of human malignant melanoma cells by glucocorticoids.
    DiSorbo DM; McNulty B; Nathanson L
    Cancer Res; 1983 Jun; 43(6):2664-7. PubMed ID: 6850583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of growth in vitro by glucocorticoids in mouse embryonic facial mesenchyme cells.
    Salomon DS; Pratt RM
    J Cell Physiol; 1978 Dec; 97(3 Pt 1):315-27. PubMed ID: 730772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucocorticoids suppress tumor angiogenesis and in vivo growth of prostate cancer cells.
    Yano A; Fujii Y; Iwai A; Kageyama Y; Kihara K
    Clin Cancer Res; 2006 May; 12(10):3003-9. PubMed ID: 16707595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture.
    Hill SM; Blask DE
    Cancer Res; 1988 Nov; 48(21):6121-6. PubMed ID: 3167858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines.
    Benz C; Hollander C; Miller B
    Cancer Res; 1986 May; 46(5):2276-81. PubMed ID: 3697973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein kinase C mediated anti-proliferative glucocorticoid-sphinganine synergism in cultured Pollard III prostate tumor cells.
    Sosnowski J; Stetter-Neel C; Cole D; Durham JP; Mawhinney MG
    J Urol; 1997 Jul; 158(1):269-74. PubMed ID: 9186373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormone responsive human breast cancer in long-term tissue culture: effect of insulin.
    Osborne CK; Bolan G; Monaco ME; Lippman ME
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4536-40. PubMed ID: 1070004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucocorticoids enhance the mitogenic action of insulin in serum-free cultures of chick embryo cells.
    Baker JB; Simmer RL; Glenn KC; Cunningham DD
    J Cell Physiol; 1979 Mar; 98(3):561-70. PubMed ID: 438300
    [No Abstract]   [Full Text] [Related]  

  • 39. High-dose pyridoxal supplemented culture medium inhibits the growth of a human malignant melanoma cell line.
    DiSorbo DM; Nathanson L
    Nutr Cancer; 1983; 5(1):10-5. PubMed ID: 6634429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of 17 beta estradiol and tamoxifen on the ZR-75-1 human breast cancer cell line in defined medium.
    Allegra JC; Lippman ME
    Eur J Cancer (1965); 1980 Aug; 16(8):1007-15. PubMed ID: 7439217
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.